Klichinsky Michael
Carisma Therapeutics, Inc. · Chief Scientific Officer
Klichinsky Michael is listed in filings as Chief Scientific Officer at Carisma Therapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 8, 2025, including sale activity. Recent filings connect the profile to Carisma Therapeutics, Inc. (CARM). The current snapshot covers public activity from Jun 18, 2024 to Oct 8, 2025. Reported amounts are shown as $14.5K to $31.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $31k119.3k shares | SellOct 3, 2025 | $0.2604 | $0.0042 | |
| $51k200k shares | SellOct 2, 2025 | $0.2543 | $0.0042 | |
| $42k165k shares | SellOct 1, 2025 | $0.257 | $0.0042 |